• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Shannon Ellis

Articles by Shannon Ellis

China to Establish Regulatory Biosimilars Framework

Aug. 28, 2013
By Shannon Ellis
SHANGHAI – Looking to lower costs and facilitate better health care outcomes, China is stepping up efforts to develop a regulatory framework and a market for biosimilars.
Read More

Vaccine Maker Sinovac Rises After Robust 2Q Earnings Report

Aug. 28, 2013
By Shannon Ellis
SHANGHAI – An unexpectedly strong second quarter has boosted investor interest in little-known Sinovac Biotech Ltd., a Beijing-based vaccine maker listed on Nasdaq.
Read More

China Hastens to Establish Regulatory Biosimilars Framework

Aug. 27, 2013
By Shannon Ellis
SHANGHAI – Looking to lower costs and facilitate better health care outcomes, China is stepping up efforts to develop a regulatory framework and a market for biosimilars.
Read More

Vaccine Maker Sinovac Rises After Robust 2Q Earnings Report

Aug. 26, 2013
By Shannon Ellis
SHANGHAI – An unexpectedly strong second quarter has boosted investor interest in little-known Sinovac Biotech Ltd., a Beijing-based vaccine maker listed on Nasdaq.
Read More

China's Crackdown on Illegal Pharma Ads Going Strong

Aug. 21, 2013
By Shannon Ellis
SHANGHAI – Highlighting increasing public concern over drug, device and food safety in China, a crackdown on illegal pharmaceutical advertising has led to a dramatic increase in the number of reported cases.
Read More

China's Crackdown on Illegal Pharma Ads Going Strong

Aug. 20, 2013
By Shannon Ellis
SHANGHAI – Highlighting increasing public concern over drug, device and food safety in China, a crackdown on illegal pharmaceutical advertising has led to a dramatic increase in the number of reported cases.
Read More

Biopharmas Targeted for New Invasive Pricing Probe in China

Aug. 16, 2013
By Shannon Ellis
SHANGHAI – Multinational drug companies may have to deal with much greater oversight of their pricing policies in China as regulators sharpen their focus and work to bring down costs for patients.
Read More

Xinfu Pharma Seeks to Raise ¥1.75B to Acquire Hefei Yifan

Aug. 15, 2013
By Shannon Ellis

SHANGHAI -–The travails of Zhejiang Hangzhou Xinfu Pharma, a small Chinese biotech firm that lost money several years running, are a clear warning to investors.

Read More

Sinopharm Building Biotech Research Center in China

Aug. 14, 2013
By Shannon Ellis
SHANGHAI – The announcement that China's largest pharmaceutical company will build the country's largest biotechnology research center in Wuhan is cementing the reputation of the Chinese city as a global biotech center. China National Pharmaceutical Group Corp. (Sinopharm) plans to build the center at the Wuhan National Bioindustry Base, also known as Biolake, in the city of Wuhan in Hubei Province.
Read More

Xinfu Pharma Seeks to Raise ¥1.75B to Acquire Hefei Yifan

Aug. 14, 2013
By Shannon Ellis
SHANGHAI -–The travails of Zhejiang Hangzhou Xinfu Pharma, a small Chinese biotech firm that lost money several years running, are a clear warning to investors.
Read More
Previous 1 2 … 61 62 63 64 65 66 67 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 30, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 30, 2025.
  • 3d rendering of bispecific antibodies

    Pfizer bets $6B+ on 3Sbio’s bispecific PD-1/VEGF antibody

    BioWorld
    Pfizer Inc. is paying $1.25 billion up front and up to $4.8 billion in milestone payments to gain global, ex-China rights to SSGJ-707, a PD-1/VEGF bispecific...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • KT-621: a first-in-class STAT6 degrader for Th2-driven diseases

    BioWorld Science
    STAT6 plays a central role in regulating Th2-driven immune responses. Recent studies have identified gain-of-function mutations in the STAT6 gene that are...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe